KCAS, Flowmetric and Active Biomarkers have united as a family of companies. Our organization has expanded rapidly, emerging as a leading CRO organization employing top scientific talent and business teams to provide exceptional customer service. We are uniquely positioned to provide comprehensive GLP/GCP compliant development services from early discovery support through product registration and beyond.  Thanks to our US and European locations, we support large transatlantic projects, including most global needs in bioanalytical, biomarker, cellular and molecular assay services as well as clinical kitting and storage management. The combined companies operate in state-of-the-art facilities located in Kansas City and Philadelphia, USA, Milan, Italy and Lyon, France. Our mission is to provide high-quality services to the biotech and pharmaceutical industries and to advance drug development in multiple disease areas.


A Few Quick Facts About KCAS

2023 – KCAS named one of KC’s Healthiest Companies

2022 – Acquired Active Biomarker, a company based in France, to combine our offerings to support the customers served globally

2022 – Opened New 70,000 sq ft state-of-the-art building in Olathe, KS

2022 – Acquired FlowMetric, a company focused on Flow Cytometry in Pennsylvania

2021 – Recognized as one of KC’s Top 150 Private companies in 2021 by Kansas City Business Journals

2021 – Named one of KC’s 100 Fastest-Growing Companies by Ingram’s Magazine

2020 – Named on of KC Largest Animal Health Companies by Kansas City Business Journals

2020 – Award for Best Companies to Work for by Ingrams Magazine


Things You Can Expect From KCAS

• Reliable, Clear and Regular Communication

• Innovative Problem-Solving Experience

• Commitment to Client Timeline

• Flexibility and Nimble Approach with our Clients

• Outstanding Record with Regulatory Agencies

• Commitment to Growing with You


Scroll to Top